Explore the detailed record of transactions filed by Sullivan John James, Chairman of the Board. Director active across 1 companies, notably Mesa Laboratories INC. Aggregated, 37 disclosures have been logged. Total volume traded: €3.5m. The latest transaction was filed on 15 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
25 of 37 declarations
John James Sullivan is a long-tenured leader at Mesa Laboratories, Inc. (NASDAQ: MLAB), where he serves as Chairman of the Board. His most notable leadership role was as President and Chief Executive Officer of Mesa, a position he held until September 2017. After stepping down as CEO, he remained involved with the company in a part-time investor-relations advisory capacity before fully retiring from Mesa in January 2021. That extended continuity gives him unusually deep institutional knowledge of the company, its regulated end markets, and its long-term strategic priorities.([sec.gov](https://www.sec.gov/Archives/edgar/data/724004/000143774922021076/mlab20220819_defa14a.htm?utm_source=openai)) Before leading Mesa, Sullivan built a strong scientific foundation. Company filings state that he worked as a Senior Research Scientist at the Seattle District Laboratory of the U.S. Food and Drug Administration until 1988. His academic background includes a B.S. in Biology from Western Washington University and a Ph.D. in Food Science from the University of Washington. This mix of scientific training and regulatory experience helped shape a career well suited to Mesa’s business, which focuses on instruments, quality-control solutions, and related products for highly regulated healthcare, pharmaceutical, medical device, and life-science markets.([sec.gov](https://www.sec.gov/Archives/edgar/data/724004/000143774919019008/mlab20190816_def14a.htm?utm_source=openai)) During his executive tenure, Sullivan helped guide Mesa through a period of strategic development and operating discipline. Company disclosures describe him as having a long history with Mesa and a successful track record of advancing the company toward its strategic objectives. In his current chair role, he remains a key governance figure, providing board oversight, continuity, and an experienced perspective on capital allocation, regulated-market execution, and long-term value creation. Overall, Sullivan’s profile reflects a scientist-turned-CEO whose career has been closely tied to Mesa’s evolution and to the oversight of a business serving demanding global quality-control markets.([sec.gov](https://www.sec.gov/Archives/edgar/data/724004/000143774924023040/mlab20230824_def14a.htm?utm_source=openai))